Burkitt Lymphoma
Showing 26 - 50 of 56
Acute Leukemia, Acute Myeloid Leukemia, MDS Trial in Philadelphia (CliniMACS Cell Processing System for TCRaß + T Cell and
Recruiting
- Acute Leukemia
- +7 more
- CliniMACS Cell Processing System for TCRαβ + T Cell and CD45RA Depleted Peripheral Stem Cell Addback
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Mar 21, 2022
Burkitt Lymphoma, Retinoblastoma, Diffuse Large B-cell Lymphoma Trial in Mwanza (mNavigator)
Active, not recruiting
- Burkitt Lymphoma
- +2 more
- mNavigator
-
Mwanza, Lake Zone, TanzaniaBugando Medical Centre
Mar 7, 2022
Burkitt Lymphoma, KSHV-associated Multicentric Castleman Disease, DLBCL Trial in Kampala (Rituximab and Hyaluronidase Human,
Recruiting
- Burkitt Lymphoma
- +2 more
- Rituximab and Hyaluronidase Human
- +8 more
-
Kampala, UgandaUCI-Fred Hutch Cancer Centre
Mar 9, 2022
High-grade B-cell Lymphoma, Burkitt Lymphoma, Lymphoma, B-Cell Trial in Busan, Seoul (Sepantronium Bromide)
Not yet recruiting
- High-grade B-cell Lymphoma
- +8 more
- Sepantronium Bromide
-
Busan, Korea, Republic of
- +5 more
Feb 27, 2022
Immune Responses to COVID-19 Vaccination in Lymphoma Patients
Active, not recruiting
- Classical Hodgkin Lymphoma
- +12 more
-
Bedford, Bedfordshire, United Kingdom
- +8 more
Feb 22, 2022
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Burkitt Lymphoma Trial in United States
Completed
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
- +5 more
- Hematopoietic Umbilical Cord Blood Stem Cell Transplantation
- GVHD prophylaxis
-
Duarte, California
- +15 more
Nov 2, 2021
B-cell Lymphoma, Burkitt Lymphoma, Diffuse Large B Cell Lymphoma Trial in Valhalla (Polatuzumab vedotin)
Recruiting
- B-cell Lymphoma
- +8 more
- Polatuzumab vedotin
-
Valhalla, New YorkNew York Medical Center
Oct 29, 2021
Burkitt Lymphoma, Diffuse Large B-cell Lymphoma, c-MYC Positive, Plasmablastic Lymphoma Trial in United States (EPOCH-R,
Active, not recruiting
- Burkitt Lymphoma
- +2 more
-
La Jolla, California
- +29 more
Nov 2, 2021
Children With Burkitt's Lymphoma
Recruiting
- Burkitt Lymphoma
- OBSERVATIONAL
-
Ouagadougou, Burkina Faso
- +6 more
Oct 26, 2021
Diffuse Large B Cell Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia Trial in Wuhan (BTK inhibitor+ Fludarabine +
Recruiting
- Diffuse Large B Cell Lymphoma
- +4 more
- BTK inhibitor+ Fludarabine + Cyclophosphamide + CAR-T-CD19 Cells
- Fludarabine + Cyclophosphamide + CAR-T-CD19 Cells
-
Wuhan, Hubei, ChinaUnion Hospital, Huazhong University of Science and Technology
Oct 13, 2021
Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic Leukemia in Complete Remission, Burkitt Leukemia Trial in Houston (drug,
Completed
- Acute Lymphoblastic Leukemia
- +6 more
- Cyclophosphamide
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Apr 6, 2021
Burkitt Lymphoma, CD20-Positive Neoplastic Cells Present, DLBCL Trial in Seattle (biological, procedure, drug, radiation, other)
Terminated
- Burkitt Lymphoma
- +6 more
- Anti-CD20 B9E9 scFv-Streptavidin Fusion Protein
- +11 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 30, 2020
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Burkitt Lymphoma Trial in Cincinnati (CPX-351)
Completed
- Acute Myeloid Leukemia
- +7 more
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Nov 6, 2020
Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Natural Killer Cell Malignancies Trial in Minneapolis (Infusion of Treg)
Terminated
- Acute Lymphoblastic Leukemia
- +17 more
- Infusion of Treg
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Sep 8, 2020
B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Well-differentiated Lymphocytic Lymphoma Trial in
Completed
- B-cell Chronic Lymphocytic Leukemia
- +9 more
-
Stanford, California
- +15 more
May 14, 2020
Lymphoma, Large B-Cell, Diffuse, Burkitt Lymphoma Trial (Gallium citrate)
Withdrawn
- Lymphoma, Large B-Cell, Diffuse
- Burkitt Lymphoma
- Gallium citrate
- (no location specified)
Oct 8, 2019
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +77 more
- fludarabine phosphate
- +8 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Sep 16, 2019
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Burkitt Lymphoma Trial in United States
Completed
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
- +5 more
- Haploidentical Bone Marrow Transplantation
- GVHD prophylaxis
-
Duarte, California
- +16 more
Nov 28, 2017
Lymphoid Malignancies (New or Relapsed), Acute Lymphoblastic Leukemia, Burkitt Lymphoma Trial in Philadelphia (Hyper-CVAD,
Completed
- Lymphoid Malignancies (New or Relapsed)
- +5 more
-
Philadelphia, Pennsylvania
- +1 more
Nov 10, 2017
Acute Lymphoblastic Leukemia, Burkitt Lymphoma Trial (CD19 CAR and PD-1 knock out engineered T-cells, CD19 CAR T-cells)
Not yet recruiting
- Acute Lymphoblastic Leukemia
- Burkitt Lymphoma
- CD19 CAR and PD-1 knock out engineered T-cells
- CD19 CAR T-cells
- (no location specified)
Sep 26, 2017
Burkitt Lymphoma, Precursor B-cell Lymphoblastic Leukemia-Lymphoma Trial in United States (SGN-CD19A)
Completed
- Burkitt Lymphoma
- Precursor B-cell Lymphoblastic Leukemia-Lymphoma
-
Birmingham, Alabama
- +12 more
Jun 29, 2017
Burkitt Lymphoma, B-ALL Trial in Italy (Chemotherapy-Rituximab combination)
Completed
- Burkitt Lymphoma
- B-ALL
- Chemotherapy-Rituximab combination
-
Bolzano, (bz), Italy
- +11 more
Sep 15, 2014
Non-Hodgkin's Lymphoma, Burkitt Lymphoma, Primary Effusion Lymphomas Trial in Los Angeles (Pegylated Liposomal Doxorubicin
Terminated
- Non-Hodgkin's Lymphoma
- +2 more
- Pegylated Liposomal Doxorubicin (Doxil) and Rituximab
-
Los Angeles, CaliforniaUSC/Norris Comprehensive Cancer Center and Hospital
May 20, 2014